News & Resources
CHDI - 17th Annual Huntington's Disease Therapeutics Conference
The conference will cover all aspects of HD drug development, including current and future biomarkers, novel HD therapeutic approaches, the new HD Integrated Staging System, updates on clinical trials including GENERATION HD1, and other presentations informing our understanding of HD pathophysiology.
View
GAP-Net Site Optimization Conference 2022
Join us for a unique opportunity to bring together academic and private sites outside the realm of specific Alzheimer’s disease (AD) and Parkinson’s disease (PD) clinical trials. Meet and network with leadership from clinical trial sites across North America, global pharma sponsors, and many partners in AD and PD clinical trial development. Hear from world-class sites and partners on current development barriers, best practices and strategies and engage in the future of clinical trials.
Attending this conference gives you the opportunity to engage with representatives from research sites, to hear their experiences and feedback first-hand outside the scope of working with them directly on a clinical trial. Attendees may glean site perspectives, research trends, common study barriers and innovative solutions, and share how sponsors can be more responsive to sites to increase success in recruitment and enrolment. We have received positive feedback from industry partners who have attended in the past regarding the value they gained in this “out of office” encounter opportunity.
14th Clinical Trials on Alzheimer's Disease (CTAD)
The development of the next generation of Alzheimer’s disease treatments is among the most important health needs worldwide, but presents huge challenges. The goal of the meeting is to bring together today’s worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues important to the development of the next generation of Alzheimer’s disease treatments. Clinical trial teams from worldwide centers will report on their efforts to identify new biomarkers of disease as well as more sensitive clinical assessment tools to identify those at risk for AD, to predict progression, and assess the effectiveness of new treatments.
View
MDS 2021 - International Parkinson and Movement Disorder Society
The International Parkinson and Movement Disorder Society (MDS) is a professional society of clinicians, scientists, and other healthcare professionals who are interested in Parkinson’s disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and motor control.
View
AAIC 2021 - Alzheimer's Association International Conference
Join in-person or virtually for AAIC 2021, where the world’s leading basic scientists, clinical researchers, early career investigators, clinicians and the care research community will share breaking research discoveries that will lead to methods of prevention and treatment and improvements in diagnosis for Alzheimer’s disease.
View
IXICO Webinar - Clinical and Imaging Biomarkers in Parkinsonian Syndromes
This webinar will look at clinical and imaging biomarkers in Parkinsonian syndromes to provide trial sponsors a rounded overview of key challenges and considerations.
What You Will Learn:
- A clinical overview of parkinsonian syndromes with a focus on Parkinson’s disease (PD), multiple systems atrophy (MSA) and progressive supranuclear palsy (PSP)
- Addressing diagnostic challenges when recruiting for clinical trials
- Overview of the use of current imaging biomarkers in clinical trials in Parkinson’s disease
- Introduction to emerging imaging biomarkers in Parkinson’s disease
CHDI - 16th Annual HD Therapeutics Conference
Given the uncertainties resulting from the ongoing COVID-19 pandemic, we have decided to move the 16th Annual HD Therapeutics Conference to a fully online, virtual experience. As in the past we will have scientific presentations, interactive poster sessions, and more – stay tuned for further details in the coming months.
View
AD/PD 2021 - The 15th International Conference on Alzheimer's and Parkinson's Disease
The AD/PD series of Alzheimer’s and Parkinson’s Diseases Conferences is focused on unraveling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s and other related neurodegenerative diseases. AD/PD Conferences combine distinct neurodegenerative diseases in one setting and examine their similarities and differences; a strong focus is mechanisms of disease, prevention and therapy.
At the conference, IXICO will be making following presentations:
• Michael Reinwald, PhD, will give a pre-recorded oral presentation, titled: “A deep-learning based framework for brain-atrophy measurement”
• Jack Weatheritt, PhD, will present the poster: “Automatic segmentation using deep learning for the hippocampus”
• Luis Peraza, PhD, will present two posters:
1) “An adaptive step detection algorithm for waist-worn wearable devices: a feasibility study in older adults”
2) “Added value of wearable sensors for fall risk assessment in an older adult group”
105-112 of 155 results